Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca Is Focused on Lynparza’s Label Expansion in 2017
AstraZeneca Is Focused on Lynparza’s Label Expansion in 2017
AstraZeneca Is Focused on Lynparza’s Label Expansion in 2017
Submitted by
admin
on July 10, 2017 - 11:39am
Source:
Market Realist
News Tags:
AstraZenca
Lynparza
BRCA-mutated ovarian cancer
ovarian cancer
Headline:
AstraZeneca Is Focused on Lynparza’s Label Expansion in 2017
Do Not Allow Advertisers to Use My Personal information